|
|
 |
|
Viewing report
|
|
|
|
Cardiovascular Health: A Key Area of Functional Food and Drinks Development
Euromonitor International, June 2010, Pages: 51
According to the World Health Organization, between 2009 and 2030, almost 23.6 million people will die from cardiovascular disease, mainly from heart disease and stroke, making heart health products a key food and drink development area. The report examines the sales prospects of fortified/functional heart healthy products and their role in preventative approaches to heart health.
The Cardiovascular Health: A Key Area of Functional Food and Drinks Development global briefing offers an insight into to the size and shape of the health and wellness marketplace, highlights buzz topics, emerging trends, categories and geographies as well as pressing industry issues and white spaces. It identifies the leading companies and brands, offers strategic analysis of key factors influencing wellbeing market - be they new product developments, packaging and ingredients innovations, introduction of new regulatory schemes, economic/lifestyle influences, distribution or retail pricing issues. Forecasts illustrate how the market is set to change and criteria for success
Product coverage: Health and Wellness by Category, Health and Wellness by Type
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Health and Wellness industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
.
Customers who bought this item also bought
Heart Disease in the United States 2010
Trends & Opportunities in Heart-Healthy Consumer Packaged Goods
Cardiovascular Drug Delivery - Technologies, Markets and Companies
The Future of Weight Management with Stevia, CLA and Satiety Food and Drinks: Regional Diversity
Nutraceuticals in China and Japan: Emerging Opportunities and their Crossover Potential for Western Markets
6th Asian Pacific Congress of Heart Failure (APCHF) - Post-Conference Review and Analysis
Personalized Medicine - Scientific and Commercial Aspects
Nutritional and Metabolic Bases of Cardiovascular Disease
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success
Health And Wellness In Austria
|
|
|
|
